TEBIPENEM PIVOXIL

SynDRA canonical compound SYN0033003 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	CNR1
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	pneumonia, otitis
Disease area	infectious disease, otolaryngology

All known targets

orapenem
Tebipenem pivoxilo
L-084
LJC 11,084
LJC-11084
ME-1211
ME1211
TBPM-PI
Orapenem
L 084
UNII-95AK1A52I8
LJC-11,084
95AK1A52I8
LJC 11084
2,2-dimethylpropanoyloxymethyl (4R,5S,6S)-3-[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
Tebipenempivoxil
Tebipenem [INN]
(4R,5S,6S)-(Pivaloyloxy)methyl 3-((1-(4,5-dihydrothiazol-2-yl)azetidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (4R,5S,6S)-
Tebipenem pivoxil (L-084)
Tebipenem pivoxil(L-084)
Orapenem (TN)
(1R,5S,6S)-6-[1(R)-Hydroxyethyl]-1-methyl-2-[1-(2-thiazolin-2-yl)azetidin-3-ylsulfanyl]-1-carba-2-penem-3-carboxylic acid pivaloyloxymethyl ester
MLS006011128
SCHEMBL305541
Tebipenem pivoxil [USAN:INN]
CHEMBL2107486
GTPL10864
DTXSID00167228
CHEBI:135799
EX-A1256
HY-B0396
WHO 7924
ZINC4217736
Tebipenem pivoxil (JAN/USAN/INN)
2748AH
CT0255
MFCD17215369